Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma

BACKGROUND: The aim of this research was to evaluate clinical and low-cost genetic determinants of treatment outcome in EGFR mutation positive advanced lung adenocarcinoma patients. MATERIAL AND METHODS: EGFR mutation testing and EGFR 181946C>T genotyping were performed in 101 advanced lung adeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Jokic, Vera, Savic-Vujovic, Katarina, Spasic, Jelena, Bukumiric, Zoran, Marinkovic, Mladen, Radosavljevic, Davorin, Cavic, Milena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358214/
https://www.ncbi.nlm.nih.gov/pubmed/35958274
http://dx.doi.org/10.1177/15593258221117354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358214/
https://www.ncbi.nlm.nih.gov/pubmed/35958274
http://dx.doi.org/10.1177/15593258221117354

Ejemplares similares